000 | 01852 a2200505 4500 | ||
---|---|---|---|
005 | 20250513235141.0 | ||
264 | 0 | _c20010816 | |
008 | 200108s 0 0 eng d | ||
022 | _a0148-0545 | ||
024 | 7 |
_a10.1081/dct-100103083 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKarrow, N A | |
245 | 0 | 0 |
_aEvaluation of the immunomodulatory effects of the macrolide antibiotic, clarithromycin, in female B6C3F1 mice: a 28-day oral gavage study. _h[electronic resource] |
260 |
_bDrug and chemical toxicology _cFeb 2001 |
||
300 |
_a19-37 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
650 | 0 | 4 |
_aAntibody Formation _xdrug effects |
650 | 0 | 4 |
_aAntibody-Producing Cells _xdrug effects |
650 | 0 | 4 | _aBlood Cell Count |
650 | 0 | 4 |
_aBody Weight _xdrug effects |
650 | 0 | 4 |
_aClarithromycin _xadministration & dosage |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aImmunoglobulin M _xblood |
650 | 0 | 4 | _aIntubation, Gastrointestinal |
650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
650 | 0 | 4 |
_aMacrophages _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred Strains |
650 | 0 | 4 |
_aOrgan Size _xdrug effects |
650 | 0 | 4 |
_aSpleen _xdrug effects |
650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _xdrug effects |
650 | 0 | 4 | _aToxicity Tests |
700 | 1 | _aMcCay, J A | |
700 | 1 | _aBrown, R D | |
700 | 1 | _aMusgrove, D L | |
700 | 1 | _aGermolec, D R | |
700 | 1 | _aWhite, K L | |
773 | 0 |
_tDrug and chemical toxicology _gvol. 24 _gno. 1 _gp. 19-37 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1081/dct-100103083 _zAvailable from publisher's website |
999 |
_c11242318 _d11242318 |